Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Rhegmatogenous Retinal Detachment
Interventions
DRUG

Ursodeoxycholic Acid

Trial Locations (1)

Unknown

University of Lausanne, Lausanne

All Listed Sponsors
collaborator

University of Lausanne Hospitals

OTHER

collaborator

Emory University

OTHER

lead

Francine Behar-Cohen

OTHER

NCT02841306 - Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment | Biotech Hunter | Biotech Hunter